Innovation in health care can take the form of a giant leap, a series of small refinements or a combination of the two. But innovation is always the product of collaboration and strong relationships and in this case, was helped along by a chance meeting in the hallway of a conference facility in Vienna.
Health Canada’s investment through its Organ Donation and Transplantation Collaborative, whose mandate is to help make transformative changes in organ donation and transplantation systems across Canada, has awarded $1.1 million to Nova Scotia Health, in collaboration with its key partners including: Nova Scotia Department of Health and Wellness, Canadian Donation and Transplant Research Program, Transplant Québec, and Canadian Blood Services. The purpose of the study is to gather evidence to inform legislative strategies to improve donation and to rigorously evaluate the impact of the overall implementation.
CO-VIC, the COVID-19 treatment and immunity study, will evaluate effectiveness of treatments for hospitalized patients suffering moderate to severe COVID-19 symptoms, while helping researchers discover more about immunity to the virus.